The Most Important Advances in Precision Medicine Being Presented at ASCO 2018

David Spigel, MD

Dr David Spigel reviews 3 of the most important, practice-changing topics at ASCO 2018: new therapies targeting RET in a number of tumor types, a prognostic biomarker assay to predict whether patients with breast cancer will need adjuvant hormonal therapy or chemotherapy, and the minimum level of PD-L1 positivity required to predict outcomes with immunotherapy in lung cancer.

Related Videos

September 2, 2015

Maintenance Setting

Dixie-Lee Esseltine, MD and George Mulligan, PhD discuss the challenges in the current standards of care of patients with multiple myeloma in the maintenance setting.

January 20, 2016

Discussing the Results of BBI608 Combined with Another Therapeutic Agent

Dr Wainberg and Dr Gerson talk about the results of using investigational agent BBI608 combined with another drug that is used as a standard of care.